Juming Yan

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Inflammatory Response

Dendritic Cells

Top Venues

Cancer discovery

Proceedings of the National Academy of Sciences of the United States of America

Cancer immunology research

QIMR Berghofer Medical Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

QIMR Berghofer Medical Research Institute Apr 01 2015

Australia

PHD :: School of Medicine, University of Queensland

Publications

Dongchen Yuan, Jing Hu, Xiaoman Ju, Eva Maria Putz, Simin Zheng, Stephane Koda, Guowei Sun, Xiaoran Deng, Zhi-Peng Xu, Wei Nie, Yang Zhao, Xianyang Li, William C Dougall, Simin Shao, Yan Chen, Ren-Xian Tang, Kui-Yang Zheng, Juming Yan
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages. Proceedings of the National Academy of Sciences of the United States of America 120 (47) (2023)
Juming Yan, Xian-Yang Li, Amelia Roman Aguilera, Christos Xiao, Celia Jacoberger-Foissac, Bianca Nowlan, Simon C Robson, Courtney Beers, Achim K Moesta, Nishamol Geetha, Michele W L Teng, Mark J Smyth
Control of Metastases via Myeloid CD39 and NK Cell Effector Function. Cancer immunology research 8 (3) (2020)
Juming Yan, Stacey Allen, Elizabeth McDonald, Indrajit Das, Jeffrey Y W Mak, Ligong Liu, David P Fairlie, Bronwyn S Meehan, Zhenjun Chen, Alexandra J Corbett, Antiopi Varelias, Mark J Smyth, Michele W L Teng
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1. Cancer discovery 10 (1) (2019)
Maya Kansara, Kristian Thomson, Puiyi Pang, Aurelie Dutour, Lisa Mirabello, Francine C Acher, Jean-Philippe Pin, Elizabeth G Demicco, Juming Yan, Michele W L Teng, Mark J Smyth, David M Thomas
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23. Cancer discovery 9 (11) (2019)